Strategic Analysis
Novo Nordisk SWOT Analysis: Navigating the GLP-1 Arms Race
Novo Nordisk created the GLP-1 category, but Lilly is closing fast. A strategic breakdown of the oral Wegovy bet and what it means for market share. Download the full SWOT analysis PDF.